Progestogens: therapeutic and adverse effects in early post-menopausal women.

[1]  R. Gambrell.  Use of progestogen therapy. , 1987, American journal of obstetrics and gynecology.

[2]  M. Whitehead,et al.  Assessment of the potency of orally administered progestins in women. , 1986, Fertility and sterility.

[3]  B. Schoultz.  Climacteric complaints as influenced by progestogens. , 1986 .

[4]  R. Gambrell.  Prevention of endometrial cancer with progestogens. , 1986, Maturitas.

[5]  C. Christiansen,et al.  Cyclic changes in serum cholesterol and lipoproteins following different doses of combined postmenopausal hormone replacement therapy , 1986, British journal of obstetrics and gynaecology.

[6]  D. Mishell,et al.  Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women. , 1986, American journal of obstetrics and gynecology.

[7]  B Rosner,et al.  A prospective study of postmenopausal estrogen therapy and coronary heart disease. , 1985, The New England journal of medicine.

[8]  Birkenhäger Jc.  Prevention of postmenopausal bone loss , 1985 .

[9]  T. Bäckström,et al.  CYCLICAL MOOD CHANGES AS IN THE PREMENSTRUAL TENSION SYNDROME DURING SEQUENTIAL ESTROGEN‐PROGESTAGEN POSTMENOPAUSAL REPLACEMENT THERAPY , 1985, Acta obstetricia et gynecologica Scandinavica.

[10]  B. Staland.  CONTINUOUS TREATMENT WITH A COMBINATION OF ESTROGEN AND GESTAGEN—A WAY OF AVOIDING ENDOMETRIAL STIMULATION , 1985, Acta obstetricia et gynecologica Scandinavica. Supplement.

[11]  L. Wallentin,et al.  L‐norgestrel and progesterone have different influences on plasma lipoproteins , 1983, European journal of clinical investigation.

[12]  C. Christiansen,et al.  Dose-response and withdrawal effects on climacteric symptoms after hormonal replacement therapy. A placebo-controlled therapeutic trial. , 1983, Maturitas.

[13]  C. Christiansen,et al.  Dose-response evaluation of cyclic estrogen/gestagen in postmenopausal women: placebo-controlled trial of its gynecologic and metabolic actions. , 1982, American journal of obstetrics and gynecology.

[14]  I. Schiff.  The effects of progestins on vasomotor flushes. , 1982, The Journal of reproductive medicine.

[15]  N. Siddle,et al.  Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy. , 1982, American journal of obstetrics and gynecology.

[16]  N. Siddle,et al.  Dose‐Dependent Effects of Synthetic Progestins on the Biochemistry of the Estrogenized Post‐Menopausal Endometrium , 1982, Acta obstetricia et gynecologica Scandinavica. Supplement.

[17]  V. Manninen,et al.  Effects of Different Progestogens on Lipoproteins during Postmenopausal Replacement Therapy , 1981 .

[18]  F. Neumann.  The physiological action of progesterone and the pharmacological effects of progestogens--a short review. , 1978, Postgraduate medical journal.

[19]  S. Campbell,et al.  Oestrogen therapy and the menopausal syndrome. , 1969, Clinics in obstetrics and gynaecology.

[20]  D. Thompson,et al.  Association of exogenous estrogen and endometrial carcinoma. , 1975, The New England journal of medicine.

[21]  H. Ziel,et al.  Increased risk of endometrial carcinoma among users of conjugated estrogens. , 1975, The New England journal of medicine.

[22]  B. Staland,et al.  Oral Treatment of Menopausal Symptoms with Natural Oestrogens , 1975, Acta obstetricia et gynecologica Scandinavica. Supplement.

[23]  B. Sundén.  On the diagnostic value of ultrasound in obstetrics and gynæcology , 1964, Acta obstetricia et gynecologica Scandinavica.

[24]  W. Filler,et al.  Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. , 1953, The Journal of clinical endocrinology and metabolism.